AAAAAA

   
Results: 1-13 |
Results: 13
APPARENT EXPANSION OF CD34(-LEUKEMIA() CELLS DURING THE EVOLUTION OF MYELODYSPLASTIC SYNDROMES TO ACUTE MYELOID)
Authors: SPAN LFR DAR SE SHETTY V MUNDLE SD BROADYROBINSON L ALVI S RAYMAKERS RAP DEWITTE T RAZA A
Citation: Lfr. Span et al., APPARENT EXPANSION OF CD34(-LEUKEMIA() CELLS DURING THE EVOLUTION OF MYELODYSPLASTIC SYNDROMES TO ACUTE MYELOID), Leukemia, 12(11), 1998, pp. 1685-1695
IS EXCESSIVE SPONTANEOUS INTRAMEDULLARY APOPTOSIS UNIQUE TO MYELODYSPLASIA
Authors: MUNDLE SD SHETTY VT RAZA A
Citation: Sd. Mundle et al., IS EXCESSIVE SPONTANEOUS INTRAMEDULLARY APOPTOSIS UNIQUE TO MYELODYSPLASIA, Experimental hematology, 26(11), 1998, pp. 1014-1015
CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/
Authors: RAZA A ALVI S BROADYROBINSON L SHOWEL M CARTLIDGE J MUNDLE SD SHETTY VT BOROK RZ DAR SE CHOPRA HK SPAN L PARCHARIDOU A HINES C GEZER S VENUGOPAL P LOEW J SHOWEL J ALSTON D HERNANDEZ B RIFKIN S ROBIN E SHAH R GREGORY SA
Citation: A. Raza et al., CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/, Experimental hematology, 25(6), 1997, pp. 530-535
BCL-2 AND C-MYC EXPRESSION, CELL-CYCLE KINETICS AND APOPTOSIS DURING THE PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA FROM DIAGNOSIS TO BLASTIC PHASE
Authors: HANDA H HEGDE UP KOTELNIKOV VM MUNDLE SD DONG LM BURKE P ROSE S GASKIN F RAZA A PREISLER HD
Citation: H. Handa et al., BCL-2 AND C-MYC EXPRESSION, CELL-CYCLE KINETICS AND APOPTOSIS DURING THE PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA FROM DIAGNOSIS TO BLASTIC PHASE, Leukemia research, 21(6), 1997, pp. 479-489
THE EFFECTS OF 13-CIS RETINOIC ACID AND INTERFERON-ALPHA IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS IN-VIVO IN PATIENTS
Authors: HANDA H HEGDE UP KOTELNIKOV VM MUNDLE SD DONG LM BURKE P ROSE S HSU WT GASKIN F RAZA A PREISLER HD
Citation: H. Handa et al., THE EFFECTS OF 13-CIS RETINOIC ACID AND INTERFERON-ALPHA IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS IN-VIVO IN PATIENTS, Leukemia research, 21(11-12), 1997, pp. 1087-1096
ASSESSMENT OF APOPTOSIS IN RELATION TO PROLIFERATION AND MUTATIONAL STATUS OF P53 GENE IN HEAD AND NECK CANCERS
Authors: MUNDLE SD KOTELNIKOV VM WOOD NB COON JS HORVATH E TAYLOR SG LAFOLLETTE S CALDARELLI DD HUTCHINSON JC PANJE WR PREISLER HD RAZA A
Citation: Sd. Mundle et al., ASSESSMENT OF APOPTOSIS IN RELATION TO PROLIFERATION AND MUTATIONAL STATUS OF P53 GENE IN HEAD AND NECK CANCERS, International journal of oncology, 8(6), 1996, pp. 1257-1264
ENZYMATIC PROGRAMMING OF APOPTOTIC CELL-DEATH
Authors: MUNDLE SD GREGORY SA PREISLER HD RAZA A
Citation: Sd. Mundle et al., ENZYMATIC PROGRAMMING OF APOPTOTIC CELL-DEATH, Pathobiology, 64(3), 1996, pp. 161-170
INDICATION OF AN INVOLVEMENT OF INTERLEUKIN-1-BETA CONVERTING ENZYME-LIKE PROTEASE IN INTRAMEDULLARY APOPTOTIC CELL-DEATH IN THE BONE-MARROW OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: MUNDLE SD VENUGOPAL P CARTLIDGE JD PANDAV DV BROADYROBINSON L GEZER S ROBIN EL RIFKIN SR KLEIN M ALSTON DE HERNANDEZ BM ROSI D ALVI S SHETTY VT GREGORY SA RAZA A
Citation: Sd. Mundle et al., INDICATION OF AN INVOLVEMENT OF INTERLEUKIN-1-BETA CONVERTING ENZYME-LIKE PROTEASE IN INTRAMEDULLARY APOPTOTIC CELL-DEATH IN THE BONE-MARROW OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 88(7), 1996, pp. 2640-2647
CD34-VIVO LABELING INDEX (LI) THAN CD34 NEGATIVE CELLS IN MYELODYSPLASTIC SYNDROMES (MDS)( CELLS HAVE A LOWER IN)
Authors: SPAN L SHETTY V BROADYROBINSON L MUNDLE SD ALVI S BOROK R REZA S DAR S BOUKHRIS T KUMAR R VENUGOPAL P GEZER S ROBIN E RIFKIN S HINES C RAZA A
Citation: L. Span et al., CD34-VIVO LABELING INDEX (LI) THAN CD34 NEGATIVE CELLS IN MYELODYSPLASTIC SYNDROMES (MDS)( CELLS HAVE A LOWER IN), Blood, 88(10), 1996, pp. 365-365
ANTI-CYTOKINE THERAPY PRODUCES RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
Authors: RAZA A GEZER S GREGORY SA VENUGOPAL P KAIZER H DONG LM SPAN L HINES C THOMAS R ALVI S MUNDLE SD SHETTY V BOREK R LOEW J REZA S ROBIN EL RIFKIN SD ALSTON D HERNANDEZ BM SHAH R HSU WT DAR S PREISLER HD
Citation: A. Raza et al., ANTI-CYTOKINE THERAPY PRODUCES RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 2310-2310
2 IN-SITU LABELING TECHNIQUES REVEAL DIFFERENT PATTERNS OF DNA FRAGMENTATION DURING SPONTANEOUS APOPTOSIS IN-VIVO AND INDUCED APOPTOSIS IN-VITRO
Authors: MUNDLE SD GAO XZ KHAN S GREGORY SA PREISLER HD RAZA A
Citation: Sd. Mundle et al., 2 IN-SITU LABELING TECHNIQUES REVEAL DIFFERENT PATTERNS OF DNA FRAGMENTATION DURING SPONTANEOUS APOPTOSIS IN-VIVO AND INDUCED APOPTOSIS IN-VITRO, Anticancer research, 15(5), 1995, pp. 1895-1904
THE 2 IN-SITU TECHNIQUES DO NOT DIFFERENTIATE BETWEEN APOPTOSIS AND NECROSIS BUT RATHER REVEAL DISTINCT PATTERNS OF DNA FRAGMENTATION IN APOPTOSIS
Authors: MUNDLE SD
Citation: Sd. Mundle, THE 2 IN-SITU TECHNIQUES DO NOT DIFFERENTIATE BETWEEN APOPTOSIS AND NECROSIS BUT RATHER REVEAL DISTINCT PATTERNS OF DNA FRAGMENTATION IN APOPTOSIS, Laboratory investigation, 72(5), 1995, pp. 611-612
SUPPRESSION OF DNA-SYNTHESIS AND INDUCTION OF APOPTOSIS IN RAT PROSTRATE BY HUMAN SEMINAL PLASMA INHIBIN (HSPI)
Authors: MUNDLE SD SHETH NA
Citation: Sd. Mundle et Na. Sheth, SUPPRESSION OF DNA-SYNTHESIS AND INDUCTION OF APOPTOSIS IN RAT PROSTRATE BY HUMAN SEMINAL PLASMA INHIBIN (HSPI), Cell biology international, 17(6), 1993, pp. 587-594
Risultati: 1-13 |